findmyKOL

Ronald Bukowski, MD

Enriched profile

Emeritus Staff, Cleveland Clinic Taussig Cancer Institute; Director, Bukowski Consulting, LLC · Cleveland Clinic Taussig Cancer Institute (Emeritus)

ORCIDNone on fileNPI↗
✓ Full profile
Region🇺🇸 Cleveland, OH · Midwest · United StatesSpecialtyHematology / OncologyFocusKidney Cancer / RCC+2
Active KOLfindmyKOL type: EliteLatest publication2023Online presenceNone verifiedPayments2021–2025NIH funding1985–1994Why? →

Ronald Bukowski is Emeritus Staff, Cleveland Clinic Taussig Cancer Institute; Director, Bukowski Consulting, LLC at Cleveland Clinic Taussig Cancer Institute (Emeritus). ClinicalTrials.gov lists 6 registered studies with this person as an investigator.

Data verified 17 Oct 2026

Overview

Updated 18 Oct 2026

Ronald Bukowski, MD, is Emeritus Staff, Cleveland Clinic Taussig Cancer Institute. The public record shows 616 publications with 45,177 citations (h-index 90), centered on Kidney Cancer / RCC, Kidney Neoplasms, Melanoma. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 9 companies, 6 NIH-funded awards (1985–1994).

  • Top research focus: Kidney Cancer / RCC
  • 6 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 9 companies

Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Kidney Cancer / RCC5 trialsKidney Neoplasms4 trialsMelanoma1 trial

Research focus

OpenAlex concept fingerprint
Kidney Cancer / RCCKidney NeoplasmsMelanoma

Drugs & molecules

across trials, industry payments and publications
Welireggeneric · BelzutifanClinical trials—Industry payments33Publications—Cabometyxgeneric · CabozantinibClinical trials—Industry payments14Publications—Opdivogeneric · NivolumabClinical trials—Industry payments14Publications—Litfulogeneric · RitlecitinibClinical trials—Industry payments10Publications—Beleodaqgeneric · BelinostatClinical trials—Industry payments1Publications—Keytrudageneric · PembrolizumabClinical trials—Industry payments1Publications—Lenvimageneric · LenvatinibClinical trials—Industry payments1Publications—Opdualaggeneric · Nivolumab / relatlimabClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments64Merck Sharp & Dohme LLCClinical trials—Industry payments30Janssen Research & Development, LLCClinical trials—Industry payments20Exelixis Inc.Clinical trials—Industry payments17Pfizer Inc.Clinical trials—Industry payments11Merck Sharp & Dohme CorporationClinical trials—Industry payments4National Cancer Institute (NCI)Clinical trials2Industry payments—The Cleveland ClinicClinical trials2Industry payments—Acrotech Biopharma Inc.Clinical trials—Industry payments1Case Comprehensive Cancer CenterClinical trials1Industry payments—Eisai Inc.Clinical trials—Industry payments1GlaxoSmithKline, LLC.Clinical trials—Industry payments1TheradexClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
90h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6clinical trials

Investigator role on registered studies.

View trials ↓
9companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
6NIH grants · 1985–1994

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 18 Oct 2026

Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 18 Oct 2026

9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

NIH funding

Updated 18 Oct 2026

6 NIH research awards on record, funded 1985–1994 per NIH RePORTER. The latest:

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Online presence

Updated 18 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    kidneycancer.org/spotlight-dr-ronald-m-bukowski

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kidneycancer.org ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 18 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Northwestern University Feinberg School of Medicine

    1967
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
  • Board Certified: Hematology

    Internal Medicine, Medical Oncology (American Board of Medical Specialties)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗

Editorial & leadership roles

journal and society appointments
  • Chairman

    Medical and Clinical Advisory Board, CSSi

    2014
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →prnewswire.com ↗
  • Member

    Oncology Drug Advisory Committee

    2008
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
  • Board of Directors

    Kidney Cancer Association

    1990
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kidneycancer.org ↗
  • Medical Steering Committee

    Kidney Cancer Association

    1990
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kidneycancer.org ↗
  • Fellow

    American College of Physicians

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
  • Member

    American Society of Clinical Oncology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
  • Member

    American Society of Hematology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
  • Member

    Southwest Oncology Group

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗

Secondary affiliations

appointments beyond the home institution
  • Professor of Medicine

    Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →prnewswire.com ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.